Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population

Medical Oncology

Volumn 31, Issue 10, 2014, Pages 1-8

  Liu, Yanqiong ^a   Sui, Jingzhe ^a   Zhai, Limin ^a   Yang, Shi ^a   Huang, Li ^a   Huang, Liying ^b   Mo, Cuiju ^a   Wu, Junrong ^a   Li, Shan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b The Third Affiliated Hospital of Guangxi Medical University The Second Nanning People s Hospital   (China)

Author keywords

Hepatocellular carcinoma; Hypoxia inducible factor 1a; Polymorphism

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHINESE; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; RISK FACTOR; VIROLOGY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84919913193     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0200-8     Document Type: Article

References (33)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. http://globocan.iarc.fr. Accessed 1 July 2014.
2. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–87.
3. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9–14.
4. Hellerbrand C, Hartmann A, Richter G, Knoll A, Wiest R, Scholmerich J, et al. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors. Dig Dis. 2001;19(4):345–51.
5. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis. 2003;24(11):1779–83.
6. Li L, Madu CO, Lu A, Lu Y. HIF-1alpha promotes a hypoxia-independent cell migration. Open Biol J. 2010;3:8–14.
7. Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, Lee JH, et al. Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer. Cancer Sci. 2010;101(6):1557–61.
8. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–32.
9. Wang W, Xu GL, Jia WD, Wang ZH, Li JS, Ma JL, et al. Expression and correlation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis. J Int Med Res. 2009;37(2):417–25.
10. Huang GW, Yang LY, Lu WQ. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival. World J Gastroenterol. 2005;11(11):1705–8.
11. Nakamura K, Zen Y, Sato Y, Kozaka K, Matsui O, Harada K, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol. 2007;38(10):1532–46.
12. Rannala B. Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics. 2001;1(3):203–21.
13. Semenza GL, Rue EA, Iyer NV, Pang MG, Kearns WG. Assignment of the hypoxia-inducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics. 1996;34(3):437–9.
14. Vainrib M, Golan M, Amir S, Dang DT, Dang LH, Bar-Shira A, et al. HIF1A C1772T polymorphism leads to HIF-1alpha mRNA overexpression in prostate cancer patients. Cancer Biol Ther. 2012;13(9):720–6.
15. Fu XS, Choi E, Bubley GJ, Balk SP. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate. 2005;63(3):215–21.
16. Ye Y, Wang M, Hu S, Shi Y, Zhang X, Zhou Y, et al. Hypoxia-inducible factor-1alpha C1772T polymorphism and cancer risk: a meta-analysis including 18,334 subjects. Cancer Invest. 2014;32(4):126–35.
17. Xu J, Xu L, Li L, You Q, Cha L. HIF-1alpha C1772T polymorphism and gastrointestinal tract cancer risk: a meta-analysis and meta-regression analysis. Genet Test Mol Biomarkers. 2013;17(12):918–25.
18. He P, Han Q, Liu J, Liu D, Zhao X, Hu T, et al. The association between hypoxia-inducible factor-1 alpha gene C1772T polymorphism and cancer risk: a meta-analysis of 37 case–control studies. PLoS One. 2013;8(12):e83441.
19. Hsiao PC, Chen MK, Su SC, Ueng KC, Chen YC, Hsieh YH, et al. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol. 2010;102(2):163–9.
20. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–8.
21. International HapMap C. The international HapMap project. Nature. 2003;426(6968):789–96.
22. Zhai G, Yang H, Ji X, Xiong F, Su J, McNutt MA, et al. Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients. Med Oncol. 2012;29(4):2744–9.
23. Liu Y, Zhang A, Liu Y, Dong J. Association analysis between the c.1804C> A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population. Med Oncol. 2014;31(3):854.
24. Chen C, Zhou H, Wei F, Jiang L, Liu X, Liu Z, et al. Increased levels of hypoxia-inducible factor-1alpha are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma. J Orthop Res. 2011;29(1):143–51.
25. Ribeiro AL, Gaspar JF, Pereira T, Ribeiro V. Lack of relevance of HIF-1alpha polymorphisms in breast cancer in a Portuguese population. Anticancer Res. 2013;33(6):2549–55.
26. Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, et al. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog. 2010;49(9):805–9.
27. Jia YF, Xiao DJ, Ma XL, Song YY, Hu R, Kong Y, et al. Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1alpha and Ki67 in human gastric cancer. Diagn Pathol. 2013;8:37.
28. Kuo WH, Shih CM, Lin CW, Cheng WE, Chen SC, Chen W, et al. Association of hypoxia inducible factor-1alpha polymorphisms with susceptibility to non-small-cell lung cancer. Transl Res. 2012;159(1):42–50.
29. Kim YH, Park IA, Park WY, Kim JW, Kim SC, Park NH, et al. Hypoxia-inducible factor 1alpha polymorphisms and early-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):2–7.
30. Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, et al. The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther. 2009;8(2):118–24.
31. Ruiz-Tovar J, Fernandez-Contreras ME, Martin-Perez E, Gamallo C. Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer. Tumori. 2012;98(3):364–9.
32. Shieh TM, Chang KW, Tu HF, Shih YH, Ko SY, Chen YC, et al. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol. 2010;46(9):e47–53.
33. Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, et al. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. Anticancer Res. 2009;29(11):4337–43.